Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Matteo Megna, Eleonora Cinelli, Elisa Camela & Gabriella Fabbrocini. (2020) Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data. Expert Review of Clinical Immunology 16:6, pages 599-620.
Read now
Read now
Christina Rogalski. (2015) Calcipotriol/betamethasone for the treatment of psoriasis: efficacy, safety, and patient acceptability. Psoriasis: Targets and Therapy 5, pages 97-107.
Read now
Read now
Jonisha Shepherd, Arash Taheri & Steven R Feldman. (2014) Once-daily topical treatment for psoriasis: calcipotriene + betamethasone two-compound topical formulation. Clinical, Cosmetic and Investigational Dermatology 7, pages 19-22.
Read now
Read now
Articles from other publishers (11)
A. Pinter, A. Reich, P. Arenberger, L. S. Gold, A. Armstrong, L. Iversen, M. Praestegaard & M. Augustin. (2023) Randomized Phase 3 trial demonstrating high efficacy, favourable safety and convenience of a novel calcipotriol and betamethasone dipropionate cream for the treatment of psoriasis. Journal of the European Academy of Dermatology and Venereology 37:11, pages 2327-2335.
Crossref
Crossref
Junrong Ren, Qi Zhu, Siyao Wang, Xiaolong Li, Zhen Sun, Nan Li, Jian Feng, Haining Ding, Sitong Dong & Hongmei Wang. (2021) Clinical efficacy and safety of using calcipotriol–betamethasone compounding agent for psoriasis treatment: a systematic review and meta-analysis. Archives of Dermatological Research 314:7, pages 633-641.
Crossref
Crossref
A. Pinter, L.J. Green, J. Selmer, M. Praestegaard, L.S. Gold & M. Augustin. (2021) A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis. Journal of the European Academy of Dermatology and Venereology 36:2, pages 228-236.
Crossref
Crossref
Craig A. Elmets, Neil J. Korman, Elizabeth Farley Prater, Emily B. Wong, Reena N. Rupani, Dario Kivelevitch, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn M.R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Michael Siegel, Benjamin Stoff, Bruce Strober, Jashin J. Wu, Vidhya Hariharan & Alan Menter. (2021) Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. Journal of the American Academy of Dermatology 84:2, pages 432-470.
Crossref
Crossref
Aiwen Xing & Lifeng Lin. (2020) Effects of treatment classifications in network meta-analysis. Research Methods in Medicine & Health Sciences 1:1, pages 12-24.
Crossref
Crossref
Kevin Robbins, Robert Bissonnette, Tomoko Maeda-Chubachi, Li Ye, Johnny Peppers, Kelly Gallagher & John E. Kraus. (2019) Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis. Journal of the American Academy of Dermatology 80:3, pages 714-721.
Crossref
Crossref
Naděžda Vojáčková. (2017) Local therapy of psoriasis. Dermatologie pro praxi 11:4, pages 174-176.
Crossref
Crossref
Atsuyuki Igarashi. (2017) Efficacy of a topical combination drug containing calcipotriol hydrate and betamethasone dipropionate for psoriasis. Journal of the Japan Organization of Clinical Dermatologists 34:4, pages 462-467.
Crossref
Crossref
A. V. Rudakova & A. N. L'vov. (2016) Fixed combination of calcipotriol and betamethasone dipropionate in the treatment of psoriasis: case-based analysis. Klinicheskaya dermatologiya i venerologiya 15:2, pages 85.
Crossref
Crossref
Giovambattista Zeppetella, Andrew Davies, Indra Eijgelshoven & Jeroen P. Jansen. (2015) Une méta-analyse en réseau de l’efficacité des analgésiques opioïdes dans la prise en charge des épisodes d’accès douloureux paroxystiques d’origine cancéreuse. Douleurs : Evaluation - Diagnostic - Traitement 16:2, pages 61-76.
Crossref
Crossref
Giovambattista Zeppetella, Andrew Davies, Indra Eijgelshoven & Jeroen P. Jansen. (2014) A Network Meta-Analysis of the Efficacy of Opioid Analgesics for the Management of Breakthrough Cancer Pain Episodes. Journal of Pain and Symptom Management 47:4, pages 772-785.e5.
Crossref
Crossref